No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract Lenalidomide in combination with R-CHOP is effective in new, untreated diffuse large B-cell lymphoma transformed from follicular lymphoma

byKathleen Lau

November 12, 2021

in StudyGraphics

RELATED REPORTS

Artificial intelligence predicts colorectal cancer in ulcerative colitis with 99% accuracy

Penpulimab and lenalidomide in combination with standard of care chemoimmunotherapy demonstrates promising safety and efficacy in diffuse large B-cell lymphoma

2 Minute Medicine Rewind February 16, 2026

Itepekimab provides beneficial effects for patients with moderate-to-severe asthma.

RelatedReports

AI Roundup

Artificial intelligence predicts colorectal cancer in ulcerative colitis with 99% accuracy

February 20, 2026

Mutation linked with decrease in cutaneous diffuse large B-cell lymphoma

Chronic Disease

Penpulimab and lenalidomide in combination with standard of care chemoimmunotherapy demonstrates promising safety and efficacy in diffuse large B-cell lymphoma

February 19, 2026

Weekly Rewinds

2 Minute Medicine Rewind February 16, 2026

February 16, 2026

HPV-targeted T-cell therapy may induce cervical cancer regression

Hematology

Chimeric antigen receptor T-cell therapy may induce sustained remission in multirefractory autoimmune hemolytic anemia

February 6, 2026

#VisualAbstract Melanomas diagnosed through routine skin checks were associated with significantly lower mortality rates

Intensive rehabilitation not superior to traditional therapy for arm function after stroke

Pre-treatment and post-treatment factors may explain discrepancies between functional outcomes and follow-up imaging infarct volume after acute ischemic stroke

Nonlinear relationship between maternal hemoglobin and infant development

Intravenous iron associated with increased infection risk compared to oral or no iron

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result